Literature DB >> 35747853

NOS3 rs1799983 and rs2070744 polymorphisms and their association with advanced chronic kidney disease and coronary heart disease in Canarian population with type 2 diabetes.

M Boronat1,2, A Tugores3, P Saavedra4, P Garay2, E Bosch5, D Lorenzo6, A Ibarra2, C García-Cantón5.   

Abstract

Context: Different polymorphisms of the endothelial nitric oxide synthase gene (NOS3) have been related to diabetic kidney disease. Objective: To evaluate the association between advanced diabetic chronic kidney disease (ACKD) and the rs1799983 and rs2070744 poymorphisms of NOS3 in a population from the Gran Canaria island. Design: Cross-sectional case-control study. Subjects and methods: Polymorphisms were genotyped in 152 subjects with ACKD secondary to type 2 diabetes [estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2], 110 subjects with type 2 diabetes for 20 or more years since diagnosis without ACKD (eGFR ≥45 mL/min/1.73m2 and albumin/creatinine ratio <300 mg/g and/or 24-h urinary albumin excretion <300 mg) and 292 healthy controls. Association between both polymorphisms and established coronary heart disease (CHD) was also analyzed in both groups with diabetes.
Results: A greater proportion of homozygous individuals for the risk allele C of rs2070744 was found among subjects with ACKD. Association between ACKD and rs2070744 was observed in a recessive genetic model, both for comparison to subjects with diabetes but no ACKD [OR 2.17 (95% CI: 1.17-4.00), p=0.014] and for comparison to healthy controls [OR 1.61 (1.03-2.52), p=0.036]. The frequency of the C allele was significantly higher among subjects with CHD, but only in the group with ACKD. No associations were found for rs1799983. Conclusions: NOS3 rs2070744 is associated with ACKD in population with type 2 diabetes from Gran Canaria. A link between this genetic variant and CHD in Canarian subjects with type 2 diabetes could be restricted to cases with ACKD. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  NOS3; chronic kidney disease; coronary heart disease; diabetic nephropathy; endothelial nitric oxide synthase; type 2 diabetes

Year:  2021        PMID: 35747853      PMCID: PMC9206159          DOI: 10.4183/aeb.2021.440

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  36 in total

1.  Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis.

Authors:  Elias Zintzaras; Georgios Kitsios; Ioannis Stefanidis
Journal:  Hypertension       Date:  2006-08-28       Impact factor: 10.190

2.  Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.

Authors:  Roland Veelken; Karl F Hilgers; Andrea Hartner; Alexander Haas; Kirsten P Böhmer; R Bernd Sterzel
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

3.  The Endothelial Nitric Oxide Synthase Gene Polymorphism is Associated with the Susceptibility to Immunoglobulin a Nephropathy in Chinese Population.

Authors:  Jie Gao; Meng Wang; Linting Wei; Dan Niu; Jiali Wei; Yan Ou; Tianbo Jin; Qiaoling Yu; Xinghan Liu; Tian Tian; Cong Dai; Rongguo Fu; Li Wang
Journal:  Kidney Blood Press Res       Date:  2017-09-25       Impact factor: 2.687

Review 4.  Endothelial nitric oxide synthase: From biochemistry and gene structure to clinical implications of NOS3 polymorphisms.

Authors:  Gustavo H Oliveira-Paula; Riccardo Lacchini; Jose E Tanus-Santos
Journal:  Gene       Date:  2015-09-28       Impact factor: 3.688

5.  Association of eNOS gene polymorphisms with renal disease in Caucasians with type 2 diabetes.

Authors:  Kátia G Santos; Daisy Crispim; Luís H Canani; Paula T Ferrugem; Jorge L Gross; Israel Roisenberg
Journal:  Diabetes Res Clin Pract       Date:  2011-01-21       Impact factor: 5.602

Review 6.  Paradoxes of nitric oxide in the diabetic kidney.

Authors:  Radko Komers; Sharon Anderson
Journal:  Am J Physiol Renal Physiol       Date:  2003-06

7.  T(-786)-->C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease.

Authors:  Yukiteru Asakimori; Noriaki Yorioka; Yoshihiko Taniguchi; Takafumi Ito; Satoshi Ogata; Yasufumi Kyuden; Nobuoki Kohno
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

8.  Association of the nitric oxide synthase (eNOS) gene polymorphism with increased risk for both lupus glomerulonephritis and rheumatoid arthritis in a single genetically homogeneous population.

Authors:  V Vazgiourakis; P Sidiropoulos; G Bertsias; E Koutsounaki; E Fragouli; A Raptopoulou; H Kritikos; D T Boumpas; G N Goulielmos
Journal:  Lupus       Date:  2007       Impact factor: 2.911

Review 9.  Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease.

Authors:  Tian-Biao Zhou; Sheng-Sheng Yin
Journal:  Ren Fail       Date:  2013-03-07       Impact factor: 2.606

10.  Interaction between endothelial nitric oxide synthase rs1799983, cholesteryl ester-transfer protein rs708272 and angiopoietin-like protein 8 rs2278426 gene variants highly elevates the risk of type 2 diabetes mellitus and cardiovascular disease.

Authors:  Dalia El-Lebedy
Journal:  Cardiovasc Diabetol       Date:  2018-07-04       Impact factor: 9.951

View more
  1 in total

1.  CORRESPONDENCE: MNOS3 RS1799983 AND RS2070744 POLYMORPHISMS AND CHRONIC KIDNEY DISEASE AND CORONARY HEART DISEASE IN POPULATION WITH TYPE 2 DIABETES.

Authors:  R Mungmunpuntipantip; V Wiwanitkit
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.